October 08, 2026 05:23 am (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
RBI shocks borrowers with first repo rate hike since 2023; rates raised to 5.50% | ‘Completely false’: Virat Kohli reacts to ₹5 crore claim over Premanand Maharaj visit | We’re watching it very closely: US urges Russia to share more information on plague situation | This isn’t about schools: Trump blames ‘mass migration’ and Islam for violent protests across France | ‘Crash axe’ blow fractured Smit Machchhar’s skull: Shocking details emerge from flydubai cockpit horror | ‘Vote thief’ Gyanesh Kumar: Rahul Gandhi climbs barricade, waves Tricolour during explosive INDIA bloc protest | ‘Crash axe’ blow fractured Smit Machchhar’s skull: Shocking details emerge from flydubai cockpit horror | ‘He should not have been flying’: JD Vance on Flydubai co-pilot | Israel was ready to shoot down Flydubai jet if it kept flying towards Tel Aviv: Reports | 'If law wasn't followed, we can undo it': Supreme Court's big warning on SIR process amid Gyanesh Kumar row
COVI19 Antibodies
WIKIMEDIA COMMONS

Less than 10 percent of world’s population have developed coronavirus antibodies: WHO Chief Scientist

| @indiablooms | Mar 01, 2021, at 03:42 pm

Geneva/UNI: The World Health Organization (WHO) estimates that less than 10 percent of the global population have antibodies to the coronavirus, WHO Chief Scientist Soumya Swaminathan said.

"Less than 10 per cent of the world’s population actually has antibodies to this virus," Swaminathan said in a Sunday interview, released on the official WHO twitter page.

"Of course in some settings, like particularly in the very high density urban settlements, there are pockets where 50, 60 percent of the population has been exposed to the virus and has antibodies," she said.

The only way to achieve mass herd immunity is through vaccination, the WHO chief scientist stressed.

According to Swaminathan, the currently approved vaccines offer good protection against severe disease, hospitalisation and death from COVID-19. The vaccines’ effectiveness with regard to mild disease and asymptomatic coronavirus infection is still being studied.

More than 114 million coronavirus cases have been confirmed globally since the start of the pandemic last spring. According to Johns Hopkins University data, the global COVID-19 death toll stands at over 2.5 million.

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.